Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07699445 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Jul 31, 2026 to Sep 9, 2026 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Jul 31, 2026 to Sep 9, 2026
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research study examines how a medication called lumateperone may affect mood symptoms, and inflammation in adults with bipolar disorder over approximately 6 weeks. An MRI scan to calculate biological age of the brain will also be obtained at the start of the study.
Trial Details
NCT Number NCT07699445
Lead Sponsor Massachusetts General Hospital
Collaborators: Johnson & Johnson K.K. Medical Company
Conditions Bipolar Depression Depressed Phase, Obesity & Overweight
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov